• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创伤性脑损伤的纳米颗粒靶向策略

Nanoparticle targeting strategies for traumatic brain injury.

作者信息

Flores-Prieto David E, Stabenfeldt Sarah E

机构信息

School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, United States of America.

出版信息

J Neural Eng. 2024 Dec 20;21(6). doi: 10.1088/1741-2552/ad995b.

DOI:10.1088/1741-2552/ad995b
PMID:39622184
Abstract

Nanoparticle (NP)-based drug delivery systems hold immense potential for targeted therapy and diagnosis of neurological disorders, overcoming the limitations of conventional treatment modalities. This review explores the design considerations and functionalization strategies of NPs for precise targeting of the brain and central nervous system. This review discusses the challenges associated with drug delivery to the brain, including the blood-brain barrier and the complex heterogeneity of traumatic brain injury. We also examine the physicochemical properties of NPs, emphasizing the role of size, shape, and surface characteristics in their interactions with biological barriers and cellular uptake mechanisms. The review concludes by exploring the options of targeting ligands designed to augment NP affinity and retention to specific brain regions or cell types. Various targeting ligands are discussed for their ability to mimic receptor-ligand interaction, and brain-specific extracellular matrix components. Strategies to mimic viral mechanisms to increase uptake are discussed. Finally, the emergence of antibody, antibody fragments, and antibody mimicking peptides are discussed as promising targeting strategies. By integrating insights from these scientific fields, this review provides an understanding of NP-based targeting strategies for personalized medicine approaches to neurological disorders. The design considerations discussed here pave the way for the development of NP platforms with enhanced therapeutic efficacy and minimized off-target effects, ultimately advancing the field of neural engineering.

摘要

基于纳米颗粒(NP)的药物递送系统在神经疾病的靶向治疗和诊断方面具有巨大潜力,克服了传统治疗方式的局限性。本综述探讨了用于精确靶向大脑和中枢神经系统的纳米颗粒的设计考量和功能化策略。本综述讨论了与药物递送至大脑相关的挑战,包括血脑屏障和创伤性脑损伤的复杂异质性。我们还研究了纳米颗粒的物理化学性质,强调了尺寸、形状和表面特性在其与生物屏障相互作用以及细胞摄取机制中的作用。综述通过探讨旨在增强纳米颗粒对特定脑区或细胞类型的亲和力和滞留性的靶向配体选项来得出结论。讨论了各种靶向配体模拟受体 - 配体相互作用的能力以及脑特异性细胞外基质成分。还讨论了模拟病毒机制以增加摄取的策略。最后,讨论了抗体、抗体片段和抗体模拟肽作为有前景的靶向策略的出现。通过整合这些科学领域的见解,本综述提供了对基于纳米颗粒的靶向策略的理解,用于神经疾病的个性化医学方法。这里讨论的设计考量为开发具有更高治疗效果和最小脱靶效应的纳米颗粒平台铺平了道路,最终推动神经工程领域的发展。

相似文献

1
Nanoparticle targeting strategies for traumatic brain injury.创伤性脑损伤的纳米颗粒靶向策略
J Neural Eng. 2024 Dec 20;21(6). doi: 10.1088/1741-2552/ad995b.
2
Emerging nanoparticle-based strategies to provide therapeutic benefits for stroke.基于纳米颗粒的新兴策略为中风提供治疗益处。
Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-24-01492.
3
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration.推进神经疾病治疗:有机纳米颗粒作为突破血脑屏障的关键
Int J Pharm. 2025 Feb 10;670:125186. doi: 10.1016/j.ijpharm.2025.125186. Epub 2025 Jan 7.
4
The piper at the gates of brain: A systematic review of surface modification strategies on lipid nanoparticles to overcome the Blood-Brain-Barrier.脑门口的风笛手:克服血脑屏障的脂质纳米粒表面修饰策略的系统评价。
Int J Pharm. 2024 Nov 15;665:124686. doi: 10.1016/j.ijpharm.2024.124686. Epub 2024 Sep 13.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Chemotherapeutic nanoparticles for glioblastoma.用于胶质母细胞瘤的化疗纳米颗粒
Front Oncol. 2025 Aug 11;15:1641752. doi: 10.3389/fonc.2025.1641752. eCollection 2025.
7
Potential Applications of Natural Components of Traditional Chinese Medicine Delivery via Nanoparticle Drug Delivery Systems in the Treatment of Alzheimer's Disease.基于纳米颗粒给药系统的中药天然成分在阿尔茨海默病治疗中的潜在应用
Int J Nanomedicine. 2025 Jun 17;20:7781-7810. doi: 10.2147/IJN.S525960. eCollection 2025.
8
Nanotechnology-driven therapies for neurodegenerative diseases: a comprehensive review.基于纳米技术的神经退行性疾病治疗方法:全面综述。
Ther Deliv. 2024;15(12):997-1024. doi: 10.1080/20415990.2024.2401307. Epub 2024 Sep 19.
9
Cell membrane-coated nanoparticles for neurodegenerative disorders management.用于神经退行性疾病管理的细胞膜包被纳米颗粒。
Int J Pharm. 2025 Aug 20;681:125875. doi: 10.1016/j.ijpharm.2025.125875. Epub 2025 Jun 20.
10
Recent advances of engineering cell membranes for nanomedicine delivery across the blood-brain barrier.用于纳米药物跨越血脑屏障递送的工程化细胞膜的最新进展
J Nanobiotechnology. 2025 Jul 8;23(1):493. doi: 10.1186/s12951-025-03572-y.

引用本文的文献

1
Traumatic Brain Injury: Novel Experimental Approaches and Treatment Possibilities.创伤性脑损伤:新的实验方法与治疗可能性
Life (Basel). 2025 May 30;15(6):884. doi: 10.3390/life15060884.

本文引用的文献

1
Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside.设计和优化用于神经退行性疾病的 AAV 介导的基因治疗:从实验室到临床。
J Transl Med. 2024 Sep 27;22(1):866. doi: 10.1186/s12967-024-05661-2.
2
Sex-dependent improvement in traumatic brain injury outcomes after liposomal delivery of dexamethasone in mice.小鼠经脂质体递送地塞米松后创伤性脑损伤结果的性别依赖性改善。
Bioeng Transl Med. 2024 Feb 4;9(4):e10647. doi: 10.1002/btm2.10647. eCollection 2024 Jul.
3
Synthesis of Lipidated Ligands and Formulation of Glia-Specific LNPs for RNAi-Mediated BBB Protection.
脂质化配体的合成及用于 RNAi 介导的 BBB 保护的神经胶质特异性 LNPs 的制剂
J Med Chem. 2024 Aug 8;67(15):13217-13230. doi: 10.1021/acs.jmedchem.4c01176. Epub 2024 Jul 20.
4
Targeting of nanoparticles to the cerebral vasculature after traumatic brain injury.创伤性脑损伤后纳米颗粒对脑血管的靶向作用。
PLoS One. 2024 Jun 10;19(6):e0297451. doi: 10.1371/journal.pone.0297451. eCollection 2024.
5
Engineered exosomes mediated targeted delivery of neuroprotective peptide NR2B9c for the treatment of traumatic brain injury.工程化外泌体介导的神经保护肽 NR2B9c 靶向递送来治疗创伤性脑损伤。
Int J Pharm. 2024 Jan 5;649:123656. doi: 10.1016/j.ijpharm.2023.123656. Epub 2023 Nov 29.
6
Astrocyte-targeted siRNA delivery by adenosine-functionalized LNP in mouse TBI model.在小鼠创伤性脑损伤模型中,通过腺苷功能化脂质纳米颗粒进行星形胶质细胞靶向的小干扰RNA递送。
Mol Ther Nucleic Acids. 2023 Oct 20;34:102065. doi: 10.1016/j.omtn.2023.102065. eCollection 2023 Dec 12.
7
Smart nanoparticles for cancer therapy.智能纳米颗粒用于癌症治疗。
Signal Transduct Target Ther. 2023 Nov 3;8(1):418. doi: 10.1038/s41392-023-01642-x.
8
Silica nanoparticles: A review of their safety and current strategies to overcome biological barriers.硅纳米颗粒:安全性综述及克服生物屏障的当前策略。
Adv Drug Deliv Rev. 2023 Dec;203:115115. doi: 10.1016/j.addr.2023.115115. Epub 2023 Oct 14.
9
Quantum Dot Biomimetic for SARS-CoV-2 to Interrogate Blood-Brain Barrier Damage Relevant to NeuroCOVID Brain Inflammation.用于SARS-CoV-2的量子点仿生技术,以探究与神经新冠脑炎相关的血脑屏障损伤
ACS Appl Nano Mater. 2023 Aug 7;6(16):15094-15107. doi: 10.1021/acsanm.3c02719. eCollection 2023 Aug 25.
10
Enhanced in vivo blood brain barrier transcytosis of macromolecular cargo using an engineered pH-sensitive mouse transferrin receptor binding nanobody.利用工程化的 pH 敏感型小鼠转铁蛋白受体结合纳米抗体增强大分子货物的体内血脑屏障转胞吞作用。
Fluids Barriers CNS. 2023 Aug 24;20(1):64. doi: 10.1186/s12987-023-00462-z.